Triple-negative breast cancer (TNBC) is a heterogeneous disease representing 10–20% of cases of breast tumors, characterized by the absence of estrogen receptors (ER−) and progesterone receptors (PR−) and lack of human epidermal growth factor type 2 receptor gene amplification14. This evidence concerns the gene PGR and breast neoplasm.